Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
I’m not just a child. I’m a daughter. I’m a son. I’m also a friend, a parent, a wife, a husband… Cancer in Young People is Rare North of England Cancer Network • Average 100 young people diagnosed with cancer per year* 25 cases 16 – 18 yrs old 75 cases 19 – 24yrs old • 1% increase per year But… *NYCRIS data 5yr period 2001- 2005 & NECN 2007 data Top 5 Causes of Death* in 15-19 yr olds % of all deaths Road traffic accidents Neoplasms Other accidents Nervous system & sense organs Suicide *ICD-9 categories in England and Wales 1976-2000 35.6 10.8 8.0 6.7 6.2 Common Teenage Cancers Bone cancers Skin cancer Percentage Distribution of Cancer Cases by Age Group (yrs) Age Group (rank) 15 - 19 20 - 24 Lymphoma 27.3 (1) 24.0 (1) Leukaemia 15.1 (2) 7.7 (5) Carcinoma 11.3 (3) 21.1 (2) Malignant Brain Tumours 0.8 (4) 7.7 (5) Bone Tumours 9.7 (5) 3.4 (8) Germ Cell Neoplasms 9.6 (6) 16.9 (3) Soft Tissue Sarcoma 6.3 (7) 4.7 (7) Malignant Melanoma 5.9 (8) 10.1 (4) Miscellaneous and Unspecified 4 4.4 Overall 5-year Survival by Time Period (13-24 year olds) % surviving in time period 79-84 85-89 90-95 96-01 Leukaemia Lymphoma CNS Tumours Bone Tumours Soft Tissue Sarcomas Germ Cell Tumours Melanoma Carcinoma All Cancers 32 76 66 39 53 79 74 74 64 43 81 71 54 54 85 86 86 72 47 82 74 51 55 91 86 86 74 53 86 73 51 57 94 90 90 77 Survival Outcomes (Challenges) • Improvement in all but bone and soft tissue sarcomas • Females fared better than males – (except germ cell tumours 91% v 87% p = 0.1) • For all cancers (except ALL, CNS, STS)* 13-16 year olds worse off than younger or older • Improvements have lagged behind advances in childhood cancer Reasons for Poorer Survival • Delay in diagnosis? • Is delay due to patient or professional? • Is treatment appropriate? For this specific tumour and its biological features • Are young patients allowed to make treatment decisions? • What is clinical entry rate? • Who decides treatment? Who Should Treat Young People and Where? • Paediatricians and adult physicians • Paediatric nurses and adult trained nurses • Tail end of embryonal tumours, the rise of carcinomas • Pressing emotional and physical needs Other Challenges • Physical appearance and self esteem are critical • Fertility and sexuality • Loss of peer support/friendships • Disruption of crucial phase of education/career • Loss of independence, normality What is important to a teenager with cancer? Getting better! The support of their family Maintaining their education Having a future Improving Outcomes Guidance in Young People with Cancer* • All patients aged 16 – 18 years inclusive must be referred to a Principal Treatment Centre & Young People for Treatment • All patients aged 19 – 24 years inclusive must be offered referral to a Principal Treatment Centre (Young People) for treatment • All patients 19 – 24 years inclusive must be discussed at both a site-specific MDT meeting and a TYA MDT meeting NICE Improving Outcomes in Children & Young People with Cancer August 2005 By 2010/11 • Teenage Young Adult (TYA) MDT • TYA Principal Treatment Centre • TYA Supportive and Palliative care • Increased Access to Clinical Trials • Peer Support • TYA Workforce Challenges for Allied Health Professionals? • Variety of different professional groups at different stages in the patient pathways • Appropriate referral at right time • Active role played by patient and their families/carers • Survivors of CNS malignancy Thank You Suzanne Thompson Young People Cancer Services, North of England Cancer Network [email protected] 0191 4971536